Haloperidol-induced dystonia and parkinsonism on discontinuing metoclopramide: implications for differential thalamocortical activity.
Lauterbach
E C
EC
D000328:Adult; D001921:Brain / Q000187:drug effects*; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000139:chemically induced* / Q000150:complications; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008787:Metoclopramide / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000150:complications / Q000209:etiology*; D013375:Substance Withdrawal Syndrome
D006220:Haloperidol; D008787:Metoclopramide